A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/44079/132428_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/41528/91017_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes Predicted intracellular proteins
| ![](/images/38280/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38280/80274_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/42014/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42014/98164_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/36900/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/36900/72530_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/40215/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40199/88099_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/46715/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16778/39552_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/3595/if_selected_60x60.jpg) | ![](/images/3595/ihc_cell_selected_60x60.jpg) | ![](/images/3595/11122_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16775/38385_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/1223/if_selected_60x60.jpg) | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | ![](/images/1223/if_selected_60x60.jpg) | | ![](/images/1223/5625_A_3_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | ![](/images/36573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57503/137455_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48319/122922_A_1_10_selected_60x60.jpg) | ![](/images/48319/122919_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15066/34421_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58960/133524_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
EVA1A | Eva-1 homolog A (C. elegans) | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/8055/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8055/24360_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/5857/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/5857/18052_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
FMO5 | Flavin containing monooxygenase 5 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/12373/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/12373/30111_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
FUOM | Fucose mutarotase | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39207/96091_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10663/26384_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | ![](/images/52887/143241_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
GLYCTK | Glycerate kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| ![](/images/6913/ihc_selected_60x60.jpg) | | ![](/images/6913/ihc_cell_selected_60x60.jpg) | ![](/images/6913/19245_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | ![](/images/27501/if_selected_60x60.jpg) | ![](/images/27501/157704_A_2_6_selected_60x60.jpg) | ![](/images/27501/147514_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | Enzymes Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31059/67322_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48934/119479_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48934/119479_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
HGD | Homogentisate 1,2-dioxygenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/47374/if_selected_60x60.jpg) | | ![](/images/47374/105994_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/27442/59064_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MAMDC4 | MAM domain containing 4 | Predicted membrane proteins
| ![](/images/26377/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26377/56636_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | ![](/images/1617/ihc_cell_selected_60x60.jpg) | ![](/images/1617/7280_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38644/80024_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6277/18455_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/6653/1399_A9_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34376/117526_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PRAP1 | Proline-rich acidic protein 1 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/52451/129775_A_2_5_selected_60x60.jpg) | ![](/images/52451/129741_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
PROX1 | Prospero homeobox 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/56919/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56919/129395_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
SLC16A13 | Solute carrier family 16, member 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/18755/41727_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9819/33139_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |